Correlation Between Freeline Therapeutics and Reneo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Freeline Therapeutics and Reneo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Freeline Therapeutics and Reneo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Freeline Therapeutics Holdings and Reneo Pharmaceuticals, you can compare the effects of market volatilities on Freeline Therapeutics and Reneo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Freeline Therapeutics with a short position of Reneo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Freeline Therapeutics and Reneo Pharmaceuticals.
Diversification Opportunities for Freeline Therapeutics and Reneo Pharmaceuticals
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Freeline and Reneo is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Freeline Therapeutics Holdings and Reneo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reneo Pharmaceuticals and Freeline Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Freeline Therapeutics Holdings are associated (or correlated) with Reneo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reneo Pharmaceuticals has no effect on the direction of Freeline Therapeutics i.e., Freeline Therapeutics and Reneo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Freeline Therapeutics and Reneo Pharmaceuticals
Given the investment horizon of 90 days Freeline Therapeutics Holdings is expected to generate 2.23 times more return on investment than Reneo Pharmaceuticals. However, Freeline Therapeutics is 2.23 times more volatile than Reneo Pharmaceuticals. It trades about 0.21 of its potential returns per unit of risk. Reneo Pharmaceuticals is currently generating about -0.02 per unit of risk. If you would invest 224.00 in Freeline Therapeutics Holdings on August 31, 2024 and sell it today you would earn a total of 207.00 from holding Freeline Therapeutics Holdings or generate 92.41% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 9.55% |
Values | Daily Returns |
Freeline Therapeutics Holdings vs. Reneo Pharmaceuticals
Performance |
Timeline |
Freeline Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Reneo Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Solid
Freeline Therapeutics and Reneo Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Freeline Therapeutics and Reneo Pharmaceuticals
The main advantage of trading using opposite Freeline Therapeutics and Reneo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Freeline Therapeutics position performs unexpectedly, Reneo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reneo Pharmaceuticals will offset losses from the drop in Reneo Pharmaceuticals' long position.Freeline Therapeutics vs. Cns Pharmaceuticals | Freeline Therapeutics vs. ZyVersa Therapeutics | Freeline Therapeutics vs. Immix Biopharma | Freeline Therapeutics vs. Hepion Pharmaceuticals |
Reneo Pharmaceuticals vs. Prime Medicine, Common | Reneo Pharmaceuticals vs. Ginkgo Bioworks Holdings | Reneo Pharmaceuticals vs. Ocean Biomedical | Reneo Pharmaceuticals vs. Royalty Pharma Plc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Transaction History View history of all your transactions and understand their impact on performance |